TG Therapeutics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Alaunos Therapeutics USD 2.06M 661K 2024-12
Amgen USD 6.21B 330M 2025-03
Ardelyx USD 173.29M 14.99M 2024-12
Arrowhead Research USD 52.59M 132.85M 2024-12
Bayer EUR 32.04B 1.49B 2024-12
Biogen USD 16.98B 262.7M 2025-03
Corcept Therapeutics USD 683.28M 3.7M 2025-03
Dynavax Technologies USD 530.94M 65.86M 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
J&J USD 78.11B 6.62B 2025-03
Novartis USD 44.05B 605M 2024-12
PTC Therapeutics USD -185760000 912.31M 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
TG Therapeutics USD 222.36M 30.21M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



TG Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.